$ALMR Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.22 up 64.52% YoY
• Reported revenue of $29.43M up 82.08% YoY
• Alamar Biosciences expects full year 2026 revenue to be in the range of $116 million to $120 million, representing growth of 59% at the midpoint of the range compared to 2025.